Literature DB >> 32301363

Biologics for psoriasis patients in the COVID-19 era: more evidence, less fears.

Matteo Megna1, Angelo Ruggiero1, Claudio Marasca1, Gabriella Fabbrocini1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32301363     DOI： 10.1080/09546634.2020.1757605

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN： 0954-6634            Impact factor:   3.359


× No keyword cloud information.
  12 in total

1.  Reply to "Psoriasis exacerbation after COVID-19 vaccination: report of 14 cases from a single centre" by Sotiriou E et al.

Authors:  M Megna; L Potestio; L Gallo; G Caiazzo; A Ruggiero; G Fabbrocini
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-09-27       Impact factor: 9.228

2.  Acute exacerbation of psoriasis after COVID-19 Pfizer vaccination.

Authors:  Erick Daniel Lopez; Nismat Javed; Shubhra Upadhyay; Rahul Shekhar; Abu Baker Sheikh
Journal:  Proc (Bayl Univ Med Cent)       Date:  2021-11-15

Review 3.  The overall impact of COVID-19 on healthcare during the pandemic: A multidisciplinary point of view.

Authors:  Nastaran Sabetkish; Alireza Rahmani
Journal:  Health Sci Rep       Date:  2021-10-01

Review 4.  Psoriasis and COVID-19: A narrative review with treatment considerations.

Authors:  Ömer Faruk Elmas; Abdullah Demirbaş; Ömer Kutlu; Fatih Bağcıer; Mahmut Sami Metin; Kemal Özyurt; Necmettin Akdeniz; Mustafa Atasoy; Ümit Türsen; Torello Lotti
Journal:  Dermatol Ther       Date:  2020-07-09       Impact factor: 3.858

5.  Comment on "Psoriasis, COVID-19, and acute respiratory distress syndrome: Focusing on the risk of concomitant biological treatment".

Authors:  Banu Farabi; Shashank Bhargava; Mohamad Goldust; Mehmet Fatih Atak
Journal:  Dermatol Ther       Date:  2020-07-06       Impact factor: 3.858

6.  SARS-CoV-2 asymptomatic infection in a patient under treatment with dupilumab.

Authors:  F Caroppo; G Biolo; A Belloni Fortina
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-06-08       Impact factor: 9.228

7.  Cutaneous manifestations and considerations in COVID-19 pandemic: A systematic review.

Authors:  Farnoosh Seirafianpour; Sogand Sodagar; Arash Pour Mohammad; Parsa Panahi; Samaneh Mozafarpoor; Simin Almasi; Azadeh Goodarzi
Journal:  Dermatol Ther       Date:  2020-08-06       Impact factor: 3.858

8.  The impact of COVID-19 in patients with psoriasis: A multicenter study in Istanbul.

Authors:  Asude Kara Polat; Ilteris Oguz Topal; Ayse Serap Karadag; Hasan Aksoy; Ayse Esra Koku Aksu; Ezgi Ozkur; Tugba Ozkok Akbulut; Filiz Topaloglu Demir; Burhan Engin; Tugba Kevser Uzuncakmak; Ilknur Kıvanc Altunay
Journal:  Dermatol Ther       Date:  2020-12-30       Impact factor: 3.858

9.  SARS-CoV-2 serology in patients on biological therapy or apremilast for psoriasis: a study of 93 patients in the Italian red zone.

Authors:  S M A Ahmed; M Volontè; E Isoletta; C Vassallo; C F Tomasini; D Lilleri; P Zelini; V Musella; C Klersy; V Brazzelli
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-10-14       Impact factor: 9.228

Review 10.  COVID-19 and immunosuppressive therapy in dermatology.

Authors:  Robert A Schwartz; Swetalina Pradhan; Dedee F Murrell; Mohammad Jafferany; Olga Y Olisova; Konstantin M Lomonosov; Torello Lotti; Mohamad Goldust
Journal:  Dermatol Ther       Date:  2020-09-03       Impact factor: 3.858
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.